Affiliation:
1. Division of Gastroenterology and Hepatology, Department of Medicine Fox Chase Cancer Center Philadelphia USA
2. Division of Gastroenterology and Hepatology, Department of Medicine Weill Cornell Medicine New York USA
Abstract
Obesity and its associated comorbid conditions have been increasing globally. Endoscopic bariatric and metabolic therapies (EBMTs) were initially designed to replicate bariatric surgery physiology for those who are not or choose not to be surgical candidates. Now, newer procedures target the complicated pathophysiology underlying obesity and its comorbidities. EBMT has been categorized based on its therapeutic target (stomach or small intestine), but innovations have expanded to include extraintestinal organs including the pancreas. Gastric EBMTs, namely space‐occupying balloons, gastroplasty with suturing or plication, and aspiration therapy, are primarily used for weight loss. Small bowel EBMTs are designed to cause malabsorption, epithelial endocrine remodeling, and other changes to intestinal physiology to ultimately improve the metabolic comorbidities of obesity rather than induce weight loss alone. These include duodenal mucosal resurfacing, endoluminal bypass sleeves, and incisionless anastomosis systems. Extraluminal or pancreatic EBMT is aimed to restore the production of normal pancreatic proteins that are involved in the progression of type 2 diabetes. This review discusses the current and new technologies of metabolic bariatric endoscopy, their pros and cons, and areas for future research.
Subject
Gastroenterology,Radiology, Nuclear Medicine and imaging
Reference31 articles.
1. Health Effects of Overweight and Obesity in 195 Countries over 25 Years
2. Obesity: global epidemiology and pathogenesis
3. FryarCD CarrollMD AffulJ.Prevalence of overweight obesity and severe obesity among adults aged 20 and over: United States 1960–1962 through 2017–2018 [Internet].Hyattsville:NCHS Health E‐Stats;2020[cited 2023 Jun 9]. Available from:https://www.cdc.gov/nchs/data/hestat/obesity‐adult‐17‐18/obesity‐adult.htm
4. Obesity: Epidemiology, Pathophysiology, and Therapeutics
5. Prevalence of obesity among adults and youth: United States, 2015–2016;Hales CM;NCHS Data Brief,2017
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献